GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by APG Asset Management N.V.

APG Asset Management N.V. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 360,320 shares of the company’s stock after buying an additional 19,856 shares during the quarter. APG Asset Management N.V. owned 0.08% of GE HealthCare Technologies worth $26,197,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in GEHC. Pathway Financial Advisers LLC acquired a new stake in GE HealthCare Technologies in the first quarter worth about $25,000. BNP Paribas acquired a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $30,000. Fred Alger Management LLC purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth approximately $26,000. Rise Advisors LLC increased its stake in GE HealthCare Technologies by 241.4% during the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares in the last quarter. Finally, Riverview Trust Co purchased a new position in shares of GE HealthCare Technologies in the first quarter worth $31,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on GEHC shares. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the company from $84.00 to $74.00 in a report on Thursday. Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective for the company. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $93.92.

GE HealthCare Technologies Trading Down 0.5 %

Shares of NASDAQ:GEHC opened at $91.99 on Friday. The firm has a market capitalization of $41.99 billion, a price-to-earnings ratio of 26.90, a price-to-earnings-growth ratio of 3.40 and a beta of 1.17. The business’s 50 day moving average price is $85.13 and its 200-day moving average price is $83.32. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter last year, the business earned $0.92 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.